Case File
efta-01950672DOJ Data Set 10OtherEFTA01950672
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01950672
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey Epstein 'eeyacation
mail.com]
Cc:
Ada Clapp
From:
Alan S Halperin
Sent
Thur 10/10/2013 9:36:13 PM
No. Leon, due to his ownership of the GP entity, was 100% beneficial owner before the transaction.
IRS Circular 230 disclosure:
To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax advice
contained in this communication (including any attachments) is not intended or written to be used, and cannot be
used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (0 promoting, marketing or
recommending to another party any transaction or matter addressed herein.
Click Here for More Information
Alan S. Halperin I Partner
Paul, Weiss, FtilkInd, Wharton & Garrison LLP
1285 Avenue of the Americas I New York NV 10019-6064
wtnv pau/weiss corn
From.
'Jeffrey Epstein' <[email protected]
To:
'Ada Clapp' <
1*, Alan S HalpenniPaulWeiss@PaulWegss, 'Melanie Spinella'
Date,
10:10+2013 05:33 PM
Subject
should we consider the purchase from the trust , as a section 16 transaction.? short swing profit
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jesivacationasmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
shou
EFTA_R1_00416984
EFTA01950672
This message is intended only for the use of the Addressee and may contain
information that is privileged and confidential. If you are not the intended
recipient, you are hereby notified that any dissemination of this communication
is strictly prohibited. If you have received this communication in error, please
erase all copies of the message and its attachments and notify us immediately.
EFTA_R1_00416985
EFTA01950673
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
jesivacationasmail.comEmail
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.